Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

Cannabinoid receptor 1 (CB1) activation has been reported to reduce transient receptor potential cation channel subfamily V member 1 (TRPV1)-induced inflammatory responses and is anti-nociceptive and anti-inflammatory in corneal injury. We examined whether allosteric ligands, can modulate CB1 signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Thapa, Dinesh, Cairns, Elizabeth A., Szczesniak, Anna-Maria, Kulkarni, Pushkar M., Straiker, Alex J., Thakur, Ganesh A., Kelly, Melanie E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024337/
https://www.ncbi.nlm.nih.gov/pubmed/31968549
http://dx.doi.org/10.3390/molecules25020417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024337/
https://www.ncbi.nlm.nih.gov/pubmed/31968549
http://dx.doi.org/10.3390/molecules25020417

Ejemplares similares